NCT05445063: Safety and Efficacy of Autologous Transplantation of iPSC-RPE in the Treatment of Macular Degeneration
- State
- Under way
- Phase
- Phase 1
- People
- 10 planned
- Started
- Aug 2022
- Primary completion
- Jul 2026
- Arms
- Participants receiving intervention
- Results
- None posted
- 6 Jul 2022: Trial registered